Policy | December 27, 2023
Sonowal and Khandu lay foundation stone for capacity expansion at NEIAFMR
NEIAFMR to be developed as the national hub for folk medicine
NEIAFMR to be developed as the national hub for folk medicine
Furthering cell therapy ambition across oncology and autoimmune diseases
US FDA approval based on NEURO-TTRansform Phase III results
The plant is yet to start commercial operations
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
Leading USA based genetic testing brand officially enters the Indian market
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
Subscribe To Our Newsletter & Stay Updated
